The Anti-Infective Drugs Market, valued at US$ 134,267.21 million in 2024, is expected to see steady growth by 2025 as rising infection rates and antimicrobial resistance increase global demand. Major pharmaceutical companies continue expanding R&D pipelines, strengthening market share. Key trends include next-generation antibiotics, targeted antivirals, and combination therapies. The market scope is further broadened by government-backed initiatives and emerging-economy access programs. Despite high development costs, the overall market size is projected to expand consistently through 2032.